Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6

被引:51
作者
Spalding, TA
Burstein, ES
Wells, JW
Brann, MR
机构
[1] UNIV VERMONT,DEPT PSYCHIAT,MOL PHARMACOL SECT,BURLINGTON,VT 05405
[2] UNIV VERMONT,DEPT PHARMACOL,MOL PHARMACOL SECT,BURLINGTON,VT 05405
[3] UNIV VERMONT,VERMONT CANC CTR,BURLINGTON,VT 05405
[4] UNIV TORONTO,FAC PHARM,TORONTO,ON M5S 2S2,CANADA
[5] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5S 2S2,CANADA
关键词
D O I
10.1021/bi970565g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The m5 muscarinic acetylcholine receptor was constitutively activated by a wide range of amino acid substitutions at a residue (serine 465) that is positioned at the junction of the sixth transmembrane domain and the extracellular loop, Of 13 substitutions tested, 11 produced significant increases in constitutive activity, Replacement of serine 465 with large (phenylalanine and valine) or basic residues (arginine and lysine) increased the constitutive activity of the receptor to between 55 and 110% of the maximum response of the wild-type receptor to the agonist carbachol. Other substitutions (e.g., cysteine and leucine) increased the constitutive activity to an intermediate level (30%), while small and acidic residues (glycine, aspartate, and glutamate) caused small or insignificant increases. The increase in the constitutive activity of each mutant receptor correlated with an increase in the potency of carbachol in both binding and functional assays, with the most constitutively activated receptors showing a 40-fold decrease in the EC50 of carbachol. The negative antagonist atropine bound to and reversed the constitutive activity of all mutant receptors with equal potency. These data were fitted to a two-state model of receptor function. The data are consistent with the primary effect of substitutions to serine 465 being to selectively destabilize the inactive state of the receptor, thus favoring formation of the active state in the absence of agonists. Our data strongly support this two-state model of receptor function and identify a critical role of this domain in the activation of muscarinic receptors.
引用
收藏
页码:10109 / 10116
页数:8
相关论文
共 44 条
[1]  
Ballesteros J.A., 1995, Methods in Neurosciences, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7
[2]  
BLUML K, 1994, J BIOL CHEM, V269, P18870
[3]   IDENTIFICATION OF A FAMILY OF MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
BUCKLEY, NJ ;
YOUNG, AC ;
BRANN, MR .
SCIENCE, 1987, 237 (4814) :527-532
[4]   CLONING AND EXPRESSION OF THE HUMAN AND RAT M5 MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
YOUNG, AC ;
BRANN, MR ;
BUCKLEY, NJ .
NEURON, 1988, 1 (05) :403-410
[5]   Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells [J].
Bräuner-Osborne, H ;
Brann, MR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (01) :93-102
[6]  
BULESCO DA, 1996, MOL PHARMACOL, V49, P132
[7]   Amino acid side chains that define muscarinic receptor G-protein coupling - Studies of the third intracellular loop [J].
Burstein, ES ;
Spalding, TA ;
Brann, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :2882-2885
[8]   STRUCTURE-FUNCTION OF MUSCARINIC RECEPTOR COUPLING TO G-PROTEINS - RANDOM SATURATION MUTAGENESIS IDENTIFIES A CRITICAL DETERMINANT OF RECEPTOR AFFINITY FOR G-PROTEINS [J].
BURSTEIN, ES ;
SPALDING, TA ;
HILLEUBANKS, D ;
BRANN, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3141-3146
[9]   Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins [J].
Burstein, ES ;
Spalding, TA ;
Brann, MR .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :312-319
[10]   CONSTITUTIVE ACTIVATION OF MUSCARINIC RECEPTORS BY THE G-PROTEIN G(Q) [J].
BURSTEIN, ES ;
SPALDING, TA ;
BRAUNER-OSBORNE, H ;
BRANN, MR .
FEBS LETTERS, 1995, 363 (03) :261-263